BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12893763)

  • 21. Induction of GDF-15/NAG-1/MIC-1 in human lung carcinoma cells by retinoid-related molecules and assessment of its role in apoptosis.
    Kadara H; Schroeder CP; Lotan D; Pisano C; Lotan R
    Cancer Biol Ther; 2006 May; 5(5):518-22. PubMed ID: 16582595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cantharidic acid induces apoptosis of human leukemic HL-60 cells via c-Jun N-terminal kinase-regulated caspase-8/-9/-3 activation pathway.
    Wang SC; Chow JM; Chien MH; Lin CW; Chen HY; Hsiao PC; Yang SF
    Environ Toxicol; 2018 Apr; 33(4):514-522. PubMed ID: 29345422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of bcl-2 or bcl-XL fails to inhibit apoptosis mediated by a novel retinoid.
    Fontana JA; Sun RJ; Rishi AK; Dawson MI; Ordónez JV; Zhang Y; Tschang SH; Bhalla K; Han Z; Wyche J; Poirer G; Sheikh MS; Shroot B; Reichert U
    Oncol Res; 1998; 10(6):313-24. PubMed ID: 9848102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apoptosis induction in cancer cells by a novel analogue of 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid lacking retinoid receptor transcriptional activation activity.
    Dawson MI; Hobbs PD; Peterson VJ; Leid M; Lange CW; Feng KC; Chen Gq ; Gu J; Li H; Kolluri SK; Zhang Xk ; Zhang Y; Fontana JA
    Cancer Res; 2001 Jun; 61(12):4723-30. PubMed ID: 11406543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of the p38 and JNK/SAPK mitogen-activated protein kinase pathways during apoptosis is mediated by a novel retinoid.
    Zhang Y; Huang Y; Rishi AK; Sheikh MS; Shroot B; Reichert U; Dawson M; Poirer G; Fontana JA
    Exp Cell Res; 1999 Feb; 247(1):233-40. PubMed ID: 10047465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downmodulation of ERK activity inhibits the proliferation and induces the apoptosis of primary acute myelogenous leukemia blasts.
    Lunghi P; Tabilio A; Dall'Aglio PP; Ridolo E; Carlo-Stella C; Pelicci PG; Bonati A
    Leukemia; 2003 Sep; 17(9):1783-93. PubMed ID: 12970778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apoptosis signaling by the novel compound 3-Cl-AHPC involves increased EGFR proteolysis and accompanying decreased phosphatidylinositol 3-kinase and AKT kinase activities.
    Farhana L; Dawson MI; Huang Y; Zhang Y; Rishi AK; Reddy KB; Freeman RS; Fontana JA
    Oncogene; 2004 Mar; 23(10):1874-84. PubMed ID: 14981538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ST1926, a novel and orally active retinoid-related molecule inducing apoptosis in myeloid leukemia cells: modulation of intracellular calcium homeostasis.
    Garattini E; Parrella E; Diomede L; Gianni' M; Kalac Y; Merlini L; Simoni D; Zanier R; Ferrara FF; Chiarucci I; Carminati P; Terao M; Pisano C
    Blood; 2004 Jan; 103(1):194-207. PubMed ID: 12958071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analogues of orphan nuclear receptor small heterodimer partner ligand and apoptosis inducer (E)-4-[3-(1-adamantyl)-4-hydroxyphenyl]-3-chlorocinnamic acid. 2. Impact of 3-chloro group replacement on inhibition of proliferation and induction of apoptosis of leukemia and cancer cell lines.
    Xia Z; Correa RG; Das JK; Farhana L; Castro DJ; Yu J; Oshima RG; Fontana JA; Reed JC; Dawson MI
    J Med Chem; 2012 Jan; 55(1):233-49. PubMed ID: 22136251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of resistance to the atypical retinoid, ST1926, in the lung carcinoma cell line H460 is associated with reduced formation of DNA strand breaks and a defective DNA damage response.
    Zuco V; Zanchi C; Lanzi C; Beretta GL; Supino R; Pisano C; Barbarino M; Zanier R; Bucci F; Aulicino C; Carminati P; Zunino F
    Neoplasia; 2005 Jul; 7(7):667-77. PubMed ID: 16026646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumor Effect of the Atypical Retinoid ST1926 in Acute Myeloid Leukemia and Nanoparticle Formulation Prolongs Lifespan and Reduces Tumor Burden of Xenograft Mice.
    El-Houjeiri L; Saad W; Hayar B; Aouad P; Tawil N; Abdel-Samad R; Hleihel R; Hamie M; Mancinelli A; Pisano C; El Hajj H; Darwiche N
    Mol Cancer Ther; 2017 Oct; 16(10):2047-2057. PubMed ID: 28619754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. WP744, a novel anthracycline with enhanced proapoptotic and antileukemic activity.
    Faderl S; Estrov Z; Kantarjian HM; Harris D; Van Q; Fokt I; Przewloka T; Godlewski C; Woynarowski JM; Priebe W
    Anticancer Res; 2001; 21(6A):3777-84. PubMed ID: 11911247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-transcriptional regulation of MyD118 and GADD45 in human lung carcinoma cells during 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2- naphthalene carboxylic acid-induced apoptosis.
    Sakaue M; Adachi H; Jetten AM
    Mol Pharmacol; 1999 Apr; 55(4):668-76. PubMed ID: 10101024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation and characterization of an acute promyelocytic leukemia cell line selectively resistant to the novel antileukemic and apoptogenic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid.
    Ponzanelli I; Giannì M; Giavazzi R; Garofalo A; Nicoletti I; Reichert U; Erba E; Rambaldi A; Terao M; Garattini E
    Blood; 2000 Apr; 95(8):2672-82. PubMed ID: 10753850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of Egr-1 expression by the retinoid AHPN in human lung carcinoma cells is dependent on activated ERK1/2.
    Sakaue M; Adachi H; Dawson M; Jetten AM
    Cell Death Differ; 2001 Apr; 8(4):411-24. PubMed ID: 11550093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-leukemic effect of sodium metaarsenite (KML001) in acute myeloid leukemia with breaking-down the resistance of cytosine arabinoside.
    Yoon JS; Kim ES; Park BB; Choi JH; Won YW; Kim S; Lee YY
    Int J Oncol; 2015 May; 46(5):1953-62. PubMed ID: 25695330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells.
    Ferrajoli A; Faderl S; Van Q; Koch P; Harris D; Liu Z; Hazan-Halevy I; Wang Y; Kantarjian HM; Priebe W; Estrov Z
    Cancer Res; 2007 Dec; 67(23):11291-9. PubMed ID: 18056455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells.
    Sun SY; Yue P; Hong WK; Lotan R
    Cancer Res; 2000 Dec; 60(24):7149-55. PubMed ID: 11156424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In acute promyelocytic leukemia NB4 cells, the synthetic retinoid CD437 induces contemporaneously apoptosis, a caspase-3-mediated degradation of PML/RARalpha protein and the PML retargeting on PML-nuclear bodies.
    Giannì M; de Thé H
    Leukemia; 1999 May; 13(5):739-49. PubMed ID: 10374879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor activity of the retinoid-related molecules (E)-3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid (ST1926) and 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) in F9 teratocarcinoma: Role of retinoic acid receptor gamma and retinoid-independent pathways.
    Parrella E; Giannì M; Fratelli M; Barzago MM; Raska I; Diomede L; Kurosaki M; Pisano C; Carminati P; Merlini L; Dallavalle S; Tavecchio M; Rochette-Egly C; Terao M; Garattini E
    Mol Pharmacol; 2006 Sep; 70(3):909-24. PubMed ID: 16788091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.